Zhang Bin, Zhang Yi, Bowerman Natalie A, Schietinger Andrea, Fu Yang-Xin, Kranz David M, Rowley Donald A, Schreiber Hans
Department of Pathology and Committee on Immunology, University of Chicago, Chicago, Illinois, USA.
Cancer Res. 2008 Mar 1;68(5):1563-71. doi: 10.1158/0008-5472.CAN-07-5324.
The growth of solid tumors depends on tumor stroma. A single adoptive transfer of CD8(+) CTLs that recognize tumor antigen-loaded stromal cells, but not the cancer cells because of MHC restriction, caused long-term inhibition of tumor growth. T cells persisted and continuously destroyed CD11b(+) myeloid-derived, F4/80(+) or Gr1(+) stromal cells during homeostasis between host and cancer. Using high-affinity T-cell receptor tetramers, we found that both subpopulations of stromal cells captured tumor antigen from surrounding cancer cells. Epitopes on the captured antigen made these cells targets for antigen-specific T cells. These myeloid stromal cells are immunosuppressive, proangiogenic, and phagocytic. Elimination of these myeloid cells allowed T cells to remain active, prevented neovascularization, and prevented tumor resorption so that tumor size remained stationary. These findings show the effectiveness of adoptive CTL therapy directed against tumor stroma and open a new avenue for cancer treatments.
实体瘤的生长依赖于肿瘤基质。由于MHC限制,单次过继转移识别负载肿瘤抗原的基质细胞而非癌细胞的CD8(+)CTL,可导致肿瘤生长的长期抑制。在宿主与癌症的稳态过程中,T细胞持续存在并不断破坏CD11b(+)骨髓来源的、F4/80(+)或Gr1(+)基质细胞。使用高亲和力T细胞受体四聚体,我们发现这两个基质细胞亚群均从周围癌细胞捕获肿瘤抗原。捕获抗原上的表位使这些细胞成为抗原特异性T细胞的靶标。这些骨髓基质细胞具有免疫抑制、促血管生成和吞噬作用。消除这些骨髓细胞可使T细胞保持活性,防止新血管形成,并防止肿瘤再吸收,从而使肿瘤大小保持稳定。这些发现表明针对肿瘤基质的过继性CTL治疗的有效性,并为癌症治疗开辟了一条新途径。